Cempra announced publication of positive results from its pivotal Phase 3 clinical trial
Cempra announced publication of positive results from its pivotal Phase 3 clinical trial of solithromycin oral capsules in treatment of patients with community-acquired bacterial pneumonia in The Lancet Infectious Diseases. Solithromycin is a highly potent next-generation macrolide. February 05, 2016